As expected, a quantitative real-time polymerase chain reaction (qRT)-PCR analysis showed that TGF-β treatment reduced the mRNA levels of the epithelial marker CDH1 in NSCLC, whereas it increased the levels of the mesenchymal markers CDH2 and VIM in the tested lung cells. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.